What You Should Know:
- Cedars-Sinai Cancer and Tempus, a provider of artificial intelligence and precision medicine, are harnessing the power of big data and AI to design personalized cancer treatment options by creating virtual replicas of patients' DNA, RNA, protein and other information to help identify the most effective approach to each individual's disease.
- By creating these "molecular twins," scientists can genetically classify cancer genes and proteins of particular tumors
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
MedStar Health, MercyOne, Moffitt Cancer Center, Others Double Down on Digital Transformation
What You Should Know:
- AVIA, the nation’s leading healthcare innovation network, today announced that the following six new health system Members joined the AVIA Network to accelerate their digital strategies and advance digital capabilities: Lee Health, LifeBridge Health, MedStar Health, MercyOne, Moffitt Cancer Center, Multicare. Additionally, AVIA had a record of 100% plus renewal rate from
Read More
Ontada, Merck Partner to Facilitate Real World Evidence Studies for Cancer Care
What You Should Know:
- Ontada, McKesson’s oncology and insights business, announced a strategic agreement with Merck, known as MSD outside the United States and Canada, that will facilitate the development of real-world research excellence and innovation. This agreement enables the two healthcare leaders to harness the power of real-world evidence (RWE) towards the common goal of improving patient outcomes and the quality of cancer care.
- Ontada and Merck’s combined experience and
Read More
Jasper Health Integrates BioIntelliSense’s RPM and COVID-19 Screening Solution for Members
What You Should Know:
- Today, BioIntelliSense announced it has formed a strategic collaboration with Jasper Health, an emerging leader of digital engagement for people diagnosed with cancer.
- As part of the strategic collaboration, Jasper Health will integrate the BioIntelliSense FDA-cleared BioSticker and medical grade BioButton® wearable devices as part of its remote member engagement and guidance platform. This new offering will enable Jasper Health members to leverage the
Read More
Foundation Medicine Integrates with Epic EMR for Genomic Insights for Precision Cancer Care
What You Should Know:
- Foundation Medicine (FMI) announced today a partnership to integrate its comprehensive genomic testing services into Epic’s electronic medical record (EMR) platform, making it easier for oncologists to order comprehensive genomic tests (CGP), review results, continually access clinical and genomic information and share among their care teams in order to develop personalized treatment plans quickly and efficiently for their patients. See the full release
Read More
U of Chicago Med & COTA to Address Racial Disparities in Cancer Using RWD
What You Should Know:
- COTA, Inc., an oncology real-world data and analytics company and the University of Chicago Medicine announced a research collaboration agreement to investigate racial disparities of care in multiple myeloma to better understand differences in the diagnosis, treatment patterns, and outcomes of patients with this type of cancer.
- Multiple myeloma is the second-most-common hematologic malignancy, with an estimated 34,920 new cases and 12,410 deaths expected to occur
Read More
Medable, Aural Analytics Partner to Develop Remote Cancer Digital Solutions
What You Should Know:
- Medable announced today that it is now partnering with Aural Analytics to test and develop remote digital data tools and harmonization methods designed to assess the wellbeing of patients undergoing cancer treatment.
- The addition of Aural Analytics’ speech biomarkers application improves outcomes data with important speech and language-based information about motor, cognitive, and respiratory function furthering the scope of digital measures which can be captured
Read More
Redesign Health Spinout Jasper Health Launches AI-Driven Cancer Care Platform
What You Should Know:
- Jasper Health launched today as the first end-to-end care experience that navigates, connects, and provides actionable insights throughout the cancer journey for individuals with cancer, their caregivers, and providers.
- Jasper combines an easy-to-navigate user interface with leading oncology support to help guide Jasper Members and caregivers through the myriad of challenges that arise post-diagnosis. United by a team of digital health experts, specialized
Read More
Cancer Centers: Here’s How We Can Restart Clinical Trials Today
Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More
Outcomes4Me Raises $12M for AI-Powered Cancer Patient Empowerment Platform
What You Should Know:
- Outcomes4Me Inc., a Cambridge, MA-based developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, today announced it has raised $12 million in an oversubscribed Series A round led by Northpond Ventures, with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal Ltd, IRA Capital, and others. Andrea Jackson, a Northpond Ventures Director, will
Read More
